Penn Medicine Abramson Cancer Center

 

Videos
09:30

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "The CLEVER Trial - Targeting Disseminated Dormant Tumor Cells With Hydroxychloroquine, Everolimus, or the Combination to Prevent Recurrent BC"

FEATURING Angela DeMichele
  • 80 views
  • November 10, 2023
  • 2
08:21

SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Results from the QuANTUM-First Trial: Impact of allo-HCT in CR1 in Addition to FLT3 Inhibition With Quizartinib in AML With FLT3-Internal Tandem Duplication

FEATURING Alexander Perl
  • 41 views
  • October 17, 2023
09:47

Total Health

2023 ASCO® Direct Philadelphia: Phase 3 OVHIPEC-1 Trial Final Survival Analysis - HIPEC in Ovarian Cancer

FEATURING Anna Smith
  • 154 views
  • October 2, 2023
09:57

Total Health

2023 ASCO® Direct Philadelphia: Phase 3 SHAPE Trial - Radical vs. Simple Hysterectomy for Low-Risk Early Stage Cervical Cancer

FEATURING Anna Smith
  • 88 views
  • October 2, 2023
  • 1
10:29

Total Health

2023 ASCO® Direct Philadelphia: RUBY Trial Review - Dostarlimab + Chemo for Advanced/Recurrent Endometrial Cancer

FEATURING Anna Smith
  • 69 views
  • October 2, 2023
27:15

Total Health

Metastatic NSCLC Updates - 2023 ASCO® Direct Philadelphia

FEATURING Shayma Kazmi
  • 129 views
  • September 29, 2023
  • 1
09:27

Total Health

2023 ASCO® Direct Philadelphia: TRANSCEND CLL 004 Study - CLL/SLL Updates

FEATURING Jakub Svoboda
  • 10 views
  • September 29, 2023
05:12

Total Health

2023 ASCO® Direct Philadelphia: Phase 3 ZUMA-7 Study - R/R DLBCL Updates

FEATURING Jakub Svoboda
  • 36 views
  • September 29, 2023
15:24

Total Health

2023 ASCO® Direct Philadelphia: Hodgkin Lymphoma Updates

FEATURING Jakub Svoboda
  • 160 views
  • September 29, 2023
  • 1
18:13

Total Health

Surgical Management of CRC Liver Metastases - 2023 ASCO® Direct Philadelphia

FEATURING Robert Roses
  • 89 views
  • September 28, 2023
20:46

Total Health

Perioperative Therapy for Early Stage NSCLC - Best of Lung 2023

FEATURING Shayma Kazmi
  • 179 views
  • September 26, 2023
17:32

Total Health

ADAURA Trial Update: Osimertinib in Resected EGFRm NSCLC - Best of Lung 2023

FEATURING Shayma Kazmi
  • 107 views
  • September 25, 2023
  • 1
26:00

International Congress on Cancer Metastasis

Neoadjuvant Therapy for Resectable Melanoma

FEATURING Giorgos Karakousis
  • 170 views
  • June 4, 2023
  • 1
05:46

Penn Medicine Abramson Cancer Center

Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials

FEATURING Thomas Karasic
  • 284 views
  • May 25, 2023
  • 3
05:27

Penn Medicine Abramson Cancer Center

Treatment Strategies in ALL: Journey to MRD Negativity

FEATURING Catherine Lai
  • 65 views
  • April 28, 2023
  • 1
16:19

ASCO GI 2023 Conference Coverage

ASCO GI 2023 Exploring Immunotherapy Combinations for DDR-Deficient Pancreatic Cancer

FEATURING Kim Reiss Binder
  • 122 views
  • February 1, 2023
  • 2
09:17

Penn Medicine Abramson Cancer Center

The Role of Adjuvant Targeted Therapy in rNSCLC

FEATURING Melina Marmarelis
  • 443 views
  • November 11, 2022
  • 3
18:34

Penn Medicine Abramson Cancer Center

2022 Delivery of Care for Cancer Patients During the COVID-19 Pandemic

FEATURING Lynn Schuchter
  • 7 views
  • May 30, 2022
15:32

Penn Medicine Abramson Cancer Center

Update on Treatment of COVID-19 Infection for Cancer and Other Immunocompromised Patients

FEATURING Kathleen M. Murphy
  • 10 views
  • May 27, 2022
15:15

Penn Medicine Abramson Cancer Center

Update on Treatment and Prevention of COVID-19 in Cancer Patients

FEATURING Alfred Garfall
  • 342 views
  • May 27, 2022
  • 2
59:57

Penn Medicine Abramson Cancer Center

Penn Medicine Updates on the Advances in BRCA-Related Breast Cancer Research and Future Developments

FEATURING Susan Domchek
  • 99 views
  • May 4, 2022
54:49

Penn Medicine Abramson Cancer Center

Updates and Management of Medullary Thyroid Cancer: Genetic Testing for Patients With MTC

FEATURING Virginia Livolsi, Katherine Nathanson, Lova L. Sun, Rachel Kelz, Susan Mandel
  • 274 views
  • March 7, 2022
  • 3
12:44

Penn Medicine Abramson Cancer Center

Advances in Adjuvant Therapy in NSCLC

FEATURING Christine Ciunci
  • 874 views
  • September 14, 2021
  • 10
08:56

Penn Medicine Abramson Cancer Center

47 y/o Male With Papillary Thyroid Cancer: How to Plan Surgery Strategy? When to Consider RT?

FEATURING Susan Mandel, Ara Chalian, Samuel Swisher-Mcclure
  • 48 views
  • May 21, 2021
09:21

Penn Medicine Abramson Cancer Center

47 y/o Male With Papillary Thyroid Cancer: Radioiodine-131 Planning & Administration

FEATURING Susan Mandel, Daniel Pryma
  • 27 views
  • May 21, 2021
12:13

Penn Medicine Abramson Cancer Center

47 y/o Male With High-Risk Thyroid Cancer: How Does Surveillance Work? When Should You Start Therapy & Which Options to Choose?

FEATURING Susan Mandel, Marcia Brose
  • 23 views
  • May 20, 2021
19:24

Penn Medicine Abramson Cancer Center

47 y/o Male With High-Risk Thyroid Cancer: What Is the Right Timing for Reoperation? Can Additional Imaging Help? What Is the Role of RT?

FEATURING Susan Mandel, Marcia Brose, Ara Chalian, Daniel Pryma, Samuel Swisher-Mcclure
  • 23 views
  • May 19, 2021
07:27

Penn Medicine Abramson Cancer Center

Attributes of Low-Risk Thyroid Cancer: How to Predict Risk? AJCC TNM Staging & ATA Risk of Structural Recurrence Overview

FEATURING Susan Mandel
  • 12 views
  • March 4, 2021
07:21

Penn Medicine Abramson Cancer Center

Low-Risk Thyroid Cancer Surgery Approach: What Are the Factors Influencing the Extent of Surgery? Unilateral vs. Bilateral Thyroidectomy

FEATURING Heather Wachtel
  • 45 views
  • March 4, 2021
07:00

Penn Medicine Abramson Cancer Center

The Histopathology of Low-Risk Thyroid Cancer: How to Assess and Identify Clinical Parameters?

FEATURING Jalal Jalaly
  • 5 views
  • March 4, 2021
04:13

Penn Medicine Abramson Cancer Center

Radioiodine Therapy for Low-Risk Thyroid Cancer: When Should I-131 Therapy Be Indicated?

FEATURING Ben Cooperberg
  • 14 views
  • March 4, 2021
05:59

Penn Medicine Abramson Cancer Center

Management of Low-Risk Thyroid Cancer: Is There a Difference in Recurrence Rates Between Thyroidectomy vs. Lobectomy?

FEATURING Susan Mandel
  • 19 views
  • March 4, 2021
20:30

Penn Medicine Abramson Cancer Center

53 y/o Female With Papillary Thyroid Cancer, Two Suspicious R Lateral Neck LNs, and US FNA 1.7 cm Positive for PTC: What Are the Management Considerations?

FEATURING Ben Cooperberg, Susan Mandel, Heather Wachtel
  • 13 views
  • March 4, 2021
09:49

Penn Medicine Abramson Cancer Center

UPenn 2020 ASCO Updates on Early Local Therapy in mBC: Does ELT Improve Survival in Patients With De Novo Disease and Intact Primary Tumor?

FEATURING Alina Mateo
  • 88 views
  • December 1, 2020
  • 1
11:35

Penn Medicine Abramson Cancer Center

UPenn 2020 ASCO Updates on HER2+ Ductal Carcinoma in Site: Does Trastuzumab + RT Improve IBRTs / DFS?

FEATURING Alina Mateo
  • 69 views
  • December 1, 2020
07:01

Penn Medicine Abramson Cancer Center

UPenn 2020 ASCO Updates on mTNBC: Does the Addition of Pembro to Chemo Extend PFS?

FEATURING Jennifer Matro
  • 79 views
  • December 1, 2020
09:01

Penn Medicine Abramson Cancer Center

UPenn 2020 ASCO Updates on PARPi in mTNBC: Does Veliparib Improve Chemo Efficacy?

FEATURING Jennifer Matro
  • 16 views
  • December 1, 2020
05:41

Penn Medicine Abramson Cancer Center

UPenn 2020 ASCO Updates on Operable TNBC: What Is the Role of Adjuvant Capecitabine?

FEATURING Jennifer Matro
  • 105 views
  • December 1, 2020
  • 1
08:58

Penn Medicine Abramson Cancer Center

UPenn 2020 ASCO Updates on ET in MBC: Is Fulvestrant + Alpelisib Effective in Patients With PIK3CA Mutations Previously Treated With AI + CDK4/6 Inhibition?

FEATURING Priya Gor
  • 123 views
  • December 1, 2020
  • 1
09:35

Penn Medicine Abramson Cancer Center

UPenn 2020 ASCO Updates on Adjuvant ET in BC: In Pts Treated With an AI During the First 5 Years of ET, Does BCI Predict Benefit of Extending Treatment With an AI for Additional 2.5 vs. 5 Years?

FEATURING Priya Gor
  • 10 views
  • December 1, 2020
13:49

Penn Medicine Abramson Cancer Center

Updates on HER2+ MBC: HER2CLIMB OS/PFS Data on Tucatinib Combo in Patients With Brain Mets

FEATURING Hayley Knollman
  • 720 views
  • December 1, 2020
  • 4
09:54

Penn Medicine Abramson Cancer Center

UPenn Updates on HER2+ EBC: CT De-Escalation Using F-PET, Adjuvant Trastuzumab Emtansine + Pertuzumab Following Anthracyclines in Operable Primary BC

FEATURING Tracy D'Entremont
  • 90 views
  • December 1, 2020
  • 1
05:16

Penn Medicine Abramson Cancer Center

UPenn 2020 ASCO Updates on Stage 2/3 HER2+ BC: Do Anthracyclines Improve Efficacy of Neoadjuvant Cemo? Are They Associated With Clinically Relevant Toxicity?

FEATURING Hayley Knollman
  • 161 views
  • December 1, 2020
  • 2
09:42

Penn Medicine Abramson Cancer Center

UPenn 2020 ASCO Updates on Adjuvant ET in BC: Does the 70-Gene Signature Help Discern Which ER+ BC With High Clinical Risk Are Associated With Good Prognosis Without Chemotherapy?

FEATURING Priya Gor
  • 8 views
  • December 1, 2020
33:02

Penn Medicine

UPenn 2020 ASCO Breast Cancer Q&A: Preoperative Anthracyclines for HER2+ BC, Earlier Brain Imaging in Pts With HER2+ MBC, Extended Adjuvant Therapy, PD-L1 Testing, Ovarian Function Suppression, Capecitabine in TNBC

FEATURING Hayley Knollman, Alina Mateo, Jennifer Matro, Tracy D'Entremont
  • 276 views
  • December 1, 2020
02:33

Penn Medicine Abramson Cancer Center

TumorGlow®: Illuminating Cancer Cells in the Operating Room

  • 158 views
  • May 30, 2019
02:05

Penn Medicine Abramson Cancer Center

Advances in Precision Surgery with Penn Medicine’s TumorGlow™ Technology

FEATURING Sunil Singhal
  • 1 view
  • November 22, 2019